Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Kiniksa Inks Global License Agreement With Roche For Vixarelimab

By Vandana Singh
August 3, 9:40 AM
Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) has announced a global license agreement with Roche Holdings AG (OTC:RHHBY) and Genentech to develop and commercialize vixarelimab, a fully human…

KNSA

Read More
1 minute read
  • Earnings
  • General
  • News
  • Restaurants

Pizza Hut Parent Yum! Brands’ Q2 Earnings Miss Estimates

By Shivani Kumaresan
August 3, 9:05 AM
Yum! Brands Inc (NYSE:YUM) reported second-quarter FY22 sales growth of 2% year-on-year to $1.64 billion, missing the consensus of $1.65 billion.…

YUM

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Merck’s Two Keytruda Combo Cancer Trials Miss Primary Goal

By Vandana Singh
August 3, 8:53 AM
Merck & Co Inc’s (NYSE:MRK) Phase 3 KEYNOTE-921 trial of Keytruda combined with chemotherapy (docetaxel) did not meet its dual…

ESALF

Read More
2 minute read
  • Analyst Ratings
  • Earnings
  • General
  • Movers
  • News
  • Price Target
  • Trading Ideas
  • Travel

Why Airbnb Stock Is Moving Lower

By Adam Eckert
August 3, 8:35 AM
Airbnb Inc (NASDAQ: ABNB) shares are trading lower Wednesday after the company reported worse-than-expected top line results. Several analysts also lowered price targets on the stock.

ABNB

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

CVS Health Q2 Sales Up Across Insurance & Pharmacy, Lifts Annual Outlook

By Vandana Singh
August 3, 8:19 AM
CVS Health Corp’s (NYSE:CVS) Q2 sales increased 11% Y/Y to $80.6 billion, beating the consensus of $76.37 billion. Prescriptions filled…

CVS

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

Cornerstone Pharmaceuticals Announces Successful Completion Of Phase 1b Clinical Trial For CPI-613 In Combination With Gemcitabine And Cisplatin In Patients With Biliary Tract Cancer

By Benzinga Newsdesk
August 3, 8:12 AM
Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced the successful

RFL

Read More
2 minute read
  • Biotech
  • General
  • News

Establishment Labs Announces Complete Enrollment In Motiva US IDE Study

By Benzinga Newsdesk
August 3, 8:06 AM
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has

ESTA

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Asia
  • General
  • Government
  • News
  • Politics
  • Tech

China Might Slow Global Tech Supply Chain More As Response To Pelosi’s Taiwan Trip, Munster Warns

By Shanthi Rexaline
August 3, 4:56 AM
Political tensions between the U.S.

XLK

Read More
2 minute read
  • General
  • Media
  • News
  • Politics
  • Small Cap

Trump Could Have Taken Out Top Al-Qaeda Leader…But Didn’t Recognize His Name

By Shivdeep Dhaliwal
August 3, 3:49 AM
Former President Donald Trump had a chance to take out Ayman al-Zawahiri but did not do so because he didn’t recognize the now deceased Al Qaeda leader’s name.

DWAC

Read More
1 minute read
  • Education
  • General
  • Movers
  • Trading Ideas

Will Meta Platforms, Amazon, Apple, Netflix Or Google Stock Grow The Most By 2023?

By Henry Khederian
August 3, 3:03 AM
Every week, Benzinga conducts a survey to collect sentiment on what traders are most excited about, interested in or thinking about as they manage and build their personal portfolios. What Are FAANG Stocks? The term FAANG stocks refers to five of the most popular tech stocks traded on the NASDAQ.

AAPL

Posts pagination

Previous 1 … 2,265 2,266 2,267 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service